Introduction
Cell cycle checkpoints prevent transition from one phase of the cell cycle to the next until all processes of the present phase are completed. Defects in the checkpoint functions result in gene mutations and chromosome damages, which contribute to the development and progression of tumors. However, loss of checkpoint function in some cancer cells is considered to be associated with their sensitivity to antineoplastic treatments such as chemotherapy and radiation. Most cancer cells are deficient in G 1 checkpoint function and therefore fail to arrest in G 1 phase on exposure to genotoxic agents. Instead, they accumulate temporarily in G 2 phase. However, given that the G 2 checkpoint is also partially impaired in cancer cells, they are unable to maintain G 2 arrest and eventually die as they enter mitosis (Fingert et al., 1986; Chan et al., 1999) . This process is known as mitotic catastrophe or mitotic death (Chan et al., 1999; Roninson et al., 2001) . Downregulation or inhibition of G 2 checkpoint proteins, including p53, p21, and 14-3-3, induces G 2 checkpoint abrogation and subsequent catastrophic death in response to DNA damage (Bunz et al., 1998; Chan et al., 1999 Chan et al., , 2000 . A new strategy has therefore been developed to sensitize cancer cells to the effects of genotoxic agents with the use of small molecules that inhibit the induction of G 2 arrest by DNA damage (Sausville et al., 2001) . The induction of mitotic catastrophe is thus an important goal of cancer therapies using DNA-damaging agents. However, mitotic catastrophe has been characterized mostly by morphological observations, with the underlying molecular mechanism remaining largely unknown in human cells.
The spindle checkpoint inhibits the activity of the anaphase-promoting complex (APC) and blocks the transition from metaphase to anaphase until all chromosomes are aligned at the metaphase plate and achieve bipolar attachment to the mitotic spindle, thus ensuring accurate sister chromatid segregation during cell division. Impairment of spindle checkpoint function results in premature mitosis and missegregation of chromosomes, leading to aneuploidy (Michel et al., 2001) . The signal activating spindle checkpoint is supposed to be generated from kinetochores that either fail to bind spindle microtubules or are not experiencing the tension that normally results from bipolar attachment to the spindle. Several proteins that localize to kinetochores, including Mad1, Mad2, BubR1 (Mad3), Bub1, Bub3, and Mps1, contribute to generation of the spindle checkpoint signal. Recent observations have shown that cells having spindle checkpoint abnormalities are insensitive to Taxol, a spindle poison (O'Connor et al., 2002; Anand et al., 2003) . However, in case of DNA-damaging agents, it is largely unknown whether dysfunction of the spindle checkpoint correlates with the ineffectiveness of these drugs aimed at inducing mitotic catastrophe.
We have now characterized the dynamics of mitotic catastrophe induced by DNA damage in p53-deficient cancer cells. Most cells entering mitosis with DNA damage arrested at metaphase and subsequently underwent cell death. Furthermore, metaphase arrest prior to the catastrophe was clearly shown to result from the activation of the spindle checkpoint, and inhibition of checkpoint function using RNA interference allowed cancer cells to escape mitotic catastrophe. Our findings demonstrate that DNA damage can activate spindle checkpoint in cells with impaired G 2 checkpoint function in a way where persistent kinetochore localization of BubR1 seems to have a critical role. The spindle checkpoint function is thus required for the induction of catastrophe in cancer cells treated with DNA-damaging antineoplastic agents.
Results

Loss of G 2 checkpoint function results in mitotic cell death after DNA damage
Cancer cells with impaired G 2 checkpoint exhibit an increased sensitivity to DNA-damaging agents, to which they respond by undergoing mitotic death (Bunz et al., 1999; Borel et al., 2002) . We established a system to investigate mitotic death in response to DNA damage. To avoid the effect of G 1 checkpoint, we used aphidicolin to induce DNA damage. This drug, at concentrations between 0.3 and 1.0 mg/ml, inhibits DNA polymerases a, d, and e, and thereby induces a prolonged stall in DNA replication that prevents its completion (Borel et al., 2002) . The resulting gaps in the double-stranded DNA are recognized as DNA strand breaks (Toledo et al., 2000) and activate the DNA damage-induced G 2 checkpoint. We treated p53 þ / þ and p53 À/À HCT116 human colon cancer cells with aphidicolin (0.5 mg/ml) and examined cell cycle distribution by flow cytometry. Both p53 þ / þ and p53 À/À cells transiently arrested at S phase and subsequently entered G 2 phase (Figure 1a) . The p53 þ / þ cells arrested in G 2 phase and did not enter mitosis, whereas the p53 À/À cells were unable to maintain G 2 arrest and entered mitosis ( Figure  1a and b) . Furthermore, less than 15% of p53 þ / þ cells treated with aphidicolin for 96 h underwent cell death ( Figure 1c ). In contrast, B50% of p53 À/À cells underwent cell death after entry into mitosis. Similar to p53 À/À HCT116 cells, HeLa cells, in which the p53 is functionally inactivated by human papilloma virus-E6, entered mitosis and subsequently underwent cell death after treatment with aphidicolin (Figure 1b and c) .
To confirm that aphidicolin treatment induces DNA damage, we examined cells for the presence of the g-H2AX complex by immunofluorescence analysis using antibodies against phosphorylated histone H2AX. Double-strand breaks (DSBs) in DNA induce the rapid phosphorylation of histone H2AX on serine-139 (Rogakou et al., 1998) , which then results in the formation of g-H2AX complexes that can be detected by the antibodies (Rogakou et al., 1999) . Given that DBSs are introduced in cells even in an ordinary cultured condition (Haber, 1999) , the g-H2AX complexes were detected in a small population of cultured cells. However, treatment with aphidicolin induced a marked increase in the number of g-H2AX-positive spots apparent in the nuclei of both p53 þ / þ and p53
HCT116 cells in G 2 phase (Figure 1d , left and right panels). In addition, multiple g-H2AX-positive spots were detected on the chromosomes of p53 À/À cells that subsequently entered mitosis (Figure 1d , right panel).
Exposure to ionizing radiation at G 2 phase, which also induces DNA damage, showed effects similar to those of aphidicolin treatment in p53 þ / þ and p53
HCT116 cells. The cells were synchronized in G 0 phase by serum deprivation, returned to serum-containing medium and, after 12 h, exposed to 20 Gy of Xradiation. The p53 À/À cells entered mitosis after a transient G 2 delay and underwent cell death (see Supplemental Figure 1 ).
Aphidicolin induced the expression of both p53 and p21 proteins in p53 þ / þ HCT116 cells, but no p53 and very little p21 proteins in p53 À/À cells (Figure 1e and f). Consistent with previous observations (Bunz et al., 1998 (Bunz et al., , 1999 , these results suggest that the failure to induce sufficient expression of p21 in the p53-deficient cells results in G 2 checkpoint abrogation. To confirm that the death of p53 À/À HCT116 cells treated with aphidicolin occurs during mitosis, we blocked the G 2 -M transition in these cells by exposure to butyrolactone I, which specifically inhibits the activity of cyclin-dependent kinase 1 (Cdk1), 24 h after the onset of aphidicolin treatment. Butyrolactone I (50 mM) induced G 2 arrest and significantly suppressed cell death (see Supplemental Figure 2 ). These results thus indicate that cells having DNA damage with impaired G 2 checkpoint undergo cell death after they enter mitosis.
DNA damage induces metaphase arrest and subsequent death in p53-deficient cells
We next analysed the dynamics of mitotic catastrophe triggered by aphidicolin-induced DNA damage. To facilitate visualization of the kinetics of chromosomes in living cells, we used HeLa and p53 À/À HCT116 cells that stably express green fluorescent protein (GFP)-tagged histone H2B. Time-lapse fluorescence and differential interference contrast (DIC) microscopy using GFP-HH2B-expressing HeLa cells revealed that cells undergo mitotic catastrophe in three phases (Table 1, Figure 2a , Supplemental video 1). In the first phase, the cells entered mitosis after G 2 checkpoint abrogation and their chromosomes became aligned at the metaphase plate. The duration from nuclear envelope breakdown to metaphase alignment was slightly longer in aphidicolin-treated cells (40.0715.2 min) than in control cells (29.176.0 min). The second phase was characterized by the failure of sister chromatid separation and metaphase arrest (140.4733.9 min). In the third phase, the chromosomes at the metaphase plate began to be stretched toward the spindle poles, with some of them moving to the poles without complete segregation; we designated this phase 'the precatastrophic phase'. The precatastrophic phase persisted for 3-10 h (380.07150.4 min), after which the cells collapsed and died. The same pattern of changes was observed in GFP-HH2B-expressing p53 À/À HCT116 cells after exposure to aphidicolin (data not shown) as well as in HeLa cells treated with 20 Gy of X-radiation in G 2 phase (Figure 2b , Supplemental video 2), suggesting that the process of mitotic catastrophe observed in our experiments is not specific to a particular DNAdamaging agent or cell line.
DNA damage induces metaphase arrest by spindle checkpoint activation
We next attempted to explore the origin of the mitotic arrest of cells at precatastrophic phase. Arrest at metaphase is usually caused by the activation of the spindle checkpoint and by the inhibition of proteolysis promoted by the APC. To investigate whether the APC is inactive in precatastrophic metaphase cells, we examined the expression of cyclin B and securin, the degradation of both of which is mediated by the APC-CDC20 complex at the metaphase-anaphase transition. We also examined the expression of cyclin A, which is degraded in prometaphase before metaphase-anaphase transition (den Elzen and Pines, 2001). Immunofluorescence analysis revealed that both cyclin B and securin, but not cyclin A, were abundant in the cytoplasm of precatastrophic HeLa and p53 À/À HCT116 cells that had been treated with aphidicolin for 72 h (Figure 3a) . Immunoblot analysis also showed that, whereas cyclin A had been degraded in precatastrophic HeLa cells, both cyclin B and securin accumulated to levels similar to those apparent in cells treated with nocodazole (0.1 mg/ ml), which prevents APC activation by triggering the spindle checkpoint (Figure 3b ). These observations indicate that the APC is not activated in the precatastrophic phase of mitotic death.
To determine whether the metaphase arrest and failure to activate the APC apparent after DNA damage result from the activation of the spindle checkpoint, we analysed the subcellular distribution of BubR1 and Mad2 proteins in metaphase-arrested HeLa cells after exposure to aphidicolin or X-irradiation. Treatment with aphidicolin or X-irradiation induced uncondensed and entangled mitotic figures (Figure 4a ). Multiple spots of BubR1 immunoreactivity were apparent at kinetochores, whereas Mad2 was not detected at kinetochores in almost all these arrested cells (Figure 4a and b) . As positive controls, we examined BubR1 and Mad2 localization in cells treated with monastrol (100 mM for 24 h) or ICRF-193 (4 mM for 48 h), which induce metaphase arrest by targeting the motor protein Eg-5 and topoisomerase II, respectively. Consistent with previous observations (Kapoor et al., 2000; Mikhailov et al., 2002) , both BubR1 and Mad2 were located at kinetochores in most cells arrested at metaphase by treatment with either of these agents (Figure 4a ). These results thus suggested that the prolongation of metaphase induced by DNA damage is attributable to the activation of BubR1-related spindle checkpoint function.
To confirm that spindle checkpoint activation is required for DNA damage-induced metaphase arrest, we treated HeLa cells with Mad2 or BubR1 RNA interference. Transfection of the cells with small interfering RNAs (siRNAs) specific for Mad2 or BubR1 mRNAs resulted in time-dependent reduction of the corresponding proteins (Figure 4c ). Immunohistochemistry showed that RNAi effectively wiped out both Mad2 and BubR1 stainings on kinetochores of prometaphase cells (Figure 4d ). As described previously (Li and Benezra, 1996) , the reduction of Mad2 resulted in the abrogation of nocodazole-induced prometaphase arrest ( Figure 4e and f) ; the cells entered into mitosis, then quickly exited without cytokinesis and became tetraploid G 1 cells. In contrast, cells transfected with a control siRNAs were arrested at prometaphase after exposure to nocodazole for 24 h. Reduction of BubR1, like that of Mad2, also abrogated nocodazole-induced prometaphase arrest (Figure 4f ). Next, we transfected cells 24 h after exposure to aphidicolin with Mad2 or BubR1 siRNAs and monitored the mitotic process by HeLa/GFP-HH2B cells were treated with aphidicolin and the mitotic process was monitored from 48 h after the onset of drug treatment by time-lapse fluorescence and DIC video microscopy. b Cells were synchronized in early S phase by thymidine treatment and monitored from 6 h after release (Figure 4e and f) . Similarly, Mad2-or BubR1-deficient cells in which DNA damage was induced by ionizing radiation failed to undergo mitotic arrest (Figure 4e and f) . Flow cytometry revealed that the Mad2-deficient cells did not accumulate in M phase after aphidicolin treatment but rather divided, entered the next G 1 phase and proceeded to S phase (Figure 4g ). Whereas the mitotic index of cells transfected with the control siRNA increased in a time-dependent manner after aphidicolin treatment, that of Mad2-or BubR1-deficient cells did not (Figure 4h ). Given that Mad2 and BubR1 are thought to act cooperatively in a single pathway to inhibit the APC (Shannon et al., 2002) , our results demonstrate that metaphase arrest induced by DNA damage is mediated by spindle checkpoint activation.
Spindle checkpoint function is essential for DNA damageinduced mitotic catastrophe
Finally, we examined whether spindle checkpoint function is required for the induction of mitotic . BubR1-deficient cells exposed to aphidicolin progressed to metaphase but were unable to maintain metaphase arrest and divided rapidly (Figure 5a , Supplemental video 4). Moreover, reduction of Mad2 or BubR1 resulted in marked suppression of cell death induced by aphidicolin (Figure 5b ). In particular, focusing on cells that had entered mitosis by time-lapse video microscopy, only 6.3 or 14.3% of those deficient in Mad2 or BubR1, respectively, underwent mitotic death, whereas 48.6% of those transfected with the control siRNA did so (Figure 5c ). These data suggest that suppression of spindle checkpoint function reduces the sensitivity of cancer cells to DNA-damaging agents. Furthermore, the aphidicolin-treated Mad2-or BubR1-deficient cells underwent cell division with severe DNA damage and manifested an irregular nuclear morphology (Figure 5d ). Therefore, spindle checkpoint function is essential not only for induction of mitotic catastrophe but also for prevention of the marked morphological changes characteristic of cancer cells that have undergone DNA damage.
Discussion
We have shown that mitotic catastrophe requires not only a defective G 2 checkpoint but also intact spindle checkpoint function. Dysfunction of the spindle checkpoint in cancer cells may thus confer resistance to DNAdamaging antineoplastic drugs. Our analysis of the dynamics of mitotic catastrophe induced by DNA damage in cancer cells with impaired G 2 checkpoint function revealed that metaphase arrest is an important event in this process. Recent studies with budding yeast have shown that DNA damage induces metaphase arrest through activation of the spindle checkpoint pathway (Garber and Rine, 2002; Maringele and Lydall, 2002) . Phosphorylation of Pds1 by Chk1 has also been shown to be essential for metaphase arrest after DNA damage in budding yeast (Wang et al., 2001) . In some human cancer cells, the DNA damage-induced metaphase arrest has also been observed previously (Erenpreisa et al., 2000) . However, the mechanism of this effect has been unclear. Three lines of evidence presented here suggest that the prolonged metaphase arrest induced by DNA damage in p53-deficient cancer cells is induced by the activation of the spindle checkpoint. First, cyclin B and securin, both of which are essential targets of the APC, accumulated in the arrested cells, suggesting that the APC was not activated. Second, the spindle checkpoint kinase BubR1 was detected at kinetochores during the metaphase arrest. And third, reduction of either BubR1 or Mad2 by RNA interference abolished the metaphase arrest, resulting in abnormal mitosis. Given that BubR1, but not Mad2, was localized at the kinetochores of precatastrophic cells and that BubR1 siRNAs sufficient to wipe out this molecule on kinetochores abrogated metaphase arrest, existence of BubR1 on kinetochores seems to be critical for the activation of the spindle checkpoint. Since Mad2 was not detected at kinetochores of precatastrophic chromosomes, the microtubules-kinetochore attachment seems to be completed. Having known that the loss of interkinetochore tension inhibits the release of BubR1 from the attached kinetochores, we speculate that some of sister chromatids may not be attached in an amphitelic manner in the precatastrophic cells. This hypothesis is supported by our time-lapse movies data that cells at precatastrophic phase showed the dynamic movement of chromosomes and some fragments of chromosomes were actively stretched and dislocated from the metaphase plate to one of the poles. Since these dynamic movements of chromosomes during precatastrophic phase were immediately eliminated by the depolymerization of microtubules by nocodazole treatment (see Supplemental video 5), each chromatid is subjected to poleward pulling force generated by spindle microtubules.
Mad2 and BubR1 have been proposed to act independently as sensors for the spindle checkpoint, in which Mad2 detecting for kinetochore microtubule attachment and BubR1 detecting for interkinetochore tension, but to function cooperatively in a single pathway to inhibit APC activity, resulting in metaphase arrest (Shannon et al., 2002) . Therefore, the BubR1-dependent mitotic arrest after DNA damage was skipped not only by BubR1 depletion but also by Mad2 depletion (Figure 5a ).
Consistent with previous observations (Bunz et al., 1998 (Bunz et al., , 1999 , we have shown that p53 plays a critical role in maintenance of G 2 checkpoint and in prevention of mitotic death in response to DNA damage occurring between S and G 2 phases. Given that p53 or its related pathway is inactivated in most human cancers, abrogation of the G 2 checkpoint and consequent mitotic catastrophe likely underlie the killing of cancer cells by therapeutic agents. However, whereas some studies have shown that p53 inactivation results in an enhanced sensitivity of cancer cells to DNA-damaging agents (Fan et al., 1995; Servomaa et al., 1996; Bradford et al., 2003) , others have found that loss of p53 increases cellular resistance to such agents (Brachman et al., 1993; Fan et al., 1994) , suggesting that additional factors modify the drug sensitivity of p53-deficient cancer cells (Vogt et al., 2002) . Our results now indicate that spindle checkpoint function is a crucial factor for the induction of mitotic death in p53-deficient cells treated with DNAdamaging agents. Cancer cells with both p53 mutations and a defective spindle checkpoint are therefore not able to undergo metaphase arrest in response to DNAdamaging agents; instead, they undergo abnormal mitosis and subsequent replication of their damaged genomes as shown in Figure 4g . Although a large fraction of those damaged cells eventually became a senescence-like phenotype and/or underwent cell death in long-term culture, approximately 5-10% of cells formed colonies and rapidly grew with an aberrant nuclear morphology and a high frequency of micronuclei (data not shown).
Recently, several reports have demonstrated a positive relationship between spindle checkpoint impairment and resistance to antimicrotubule agents. (Anand et al., 2003; Masuda et al., 2003; Sudo et al., 2004) . However, the contribution of spindle checkpoint in inducing cell death after treatments of DNA-damaging agents has not been sufficiently studied previously. Masuda et al. (2003) have recently shown that there is no significant difference in the susceptibility to cis-platin between nine spindle checkpoint-proficient and four spindle checkpoint-impaired human cancer cells. However, as we have shown in this study, not only the status of spindle checkpoint but also that of p53 is important for determining the sensitivity of cancer cells to DNAdamaging agents. Spindle checkpoint function is impaired in many types of cancer cells (Li and Benezra, 1996; Takahashi et al., 1999; Saeki et al., 2002; Wang et al., 2002; Lens et al., 2003) even if there have been found few mutation of candidate genes (Cahill et al., 1998; Ru et al., 2002) . It is possible that spindle checkpoint function is affected by protein level. In fact, haploinsufficiency of Mad2 gene induces downregulation of Mad2 protein and loss of spindle checkpoint (Michel et al., 2001) . Assessment of spindle checkpoint function should thus provide important information for clinical decision-making with regard to the most appropriate treatment for advanced tumors.
Materials and methods
Cell culture and chemicals
HeLa cells were maintained in DMEM-F12 containing 10% fetal calf serum (FCS). HCT116 (p53 þ / þ and p53
) cells were kindly provided by Dr B Vogelstein and maintained in McCoy-5A containing 10% FCS. Nocodazole (Sigma, St Louis, MI, USA), aphidicolin (Wako, Osaka, Japan), butyrolactone I (Wako), monastrol (Calbiochem, San Diego, CA, USA), and ICRF-193 (Zenoaq, Fukushima, Japan) were maintained in DMSO.
Flow cytometry
The cells were collected and fixed in ice-cold 70% ethanol. The cells were treated with rat monoclonal antibodies to phosphorylated histone H3 (kindly provided by M Inagaki) (Goto et al., 1999) followed by incubation with FITC-conjugated anti-rat IgG. After further incubation for 30 min at 371C with RNase A (100 mg/ml), the cells were stained with propidium iodide (PI) (25 mg/ml) and analysed by FACScan (Becton Dickinson, Franklin Lakes, NJ, USA).
Time-lapse video microscopy
Cells stably expressing GFP-tagged histone H2B (Marumoto et al., 2003) were grown in 35-mm Delta-T dishes (Bioptechs Inc., Butler, PA, USA) containing Leibovitz's CO 2 -independent medium (Gibco). Time-lapse fluorescence and DIC video microscopy was performed with an IX70 microscope (Olympus, Tokyo, Japan); images (100-ms exposure) were acquired every 5 or 10 min with a Sensys-charge-coupled device (CCD) camera controlled by Metamorph imaging software (Universal Imaging, Downingtown, PA, USA).
RNA interference
The sequences of the siRNAs specific for human Mad2 or BubR1 were 5 0 -ACCUUUACUCGAGUGCAGA-3 0 (corresponding to nucleotides 124-142 relative to the start codon) and 5 0 -CAAUACUCUUCAGCAGCAG-3 0 (nucleotides 293-311), respectively. A double-stranded RNA targeting luciferase (GL-2: 5 0 -CGUACGCGGAAUACUUCGAdTdT-3 0 ) was used as a control. Annealing of the component strands of each siRNA and transfection were performed as described (Elbashir et al., 2001) .
Immunofluorescence analysis
Cells grown in 35-mm Petri dishes were fixed for 20 min at room temperature with 4% paraformaldehyde in phosphatebuffered saline (PBS) and then permeabilized with 0.2% Triton X-100 in PBS. The cells were incubated first with primary antibodies overnight at 41C and then for 45 min at room temperature with FITC-conjugated secondary antibodies (Biosource). The stained cells were examined with a confocal microscope (FV300, Olympus).
Antibodies
Rabbit antiserum against Mad2 was generated by injecting rabbits with recombinant GST-hsMad2 fusion protein. Mouse monoclonal antibodies to cyclin A, cyclin B1, and a-tubulin (B512) were from Transduction Laboratories. Mouse monoclonal antibodies to p53 (DO-1) and rabbit polyclonal antibodies to p21 (C19) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibodies to securin were from Zymed (South San Francisco, CA, USA).
Mouse monoclonal antibodies to BubR1 were gently kindly provided by Dr T Yen.
Abbreviations APC, anaphase-promoting complex; GFP, green fluorescent protein; DIC, differential interference contrast; CCD, chargecoupled device.
